Carcinoma, Endometrioid - 25 Studies Found Estado Estudiar Active, not recruiting Nombre del estudio: Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Condición: Fallopian Tube Carcinosarcoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Recruiting Nombre del estudio: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Recruiting Nombre del estudio: Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición: Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Drug: Cediranib Maleate Given Recruiting Nombre del estudio: Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición: Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Drug: Cediranib Maleate Given Recruiting Nombre del estudio: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Condición: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Radiation: 3-Dimensional Conformal Radiation Therapy <<< Previous